Nykode Therapeutics AS Statistics

Total Valuation

OSL:NYKD has a market cap or net worth of NOK 1.03 billion. The enterprise value is 451.80 million.

Market Cap	1.03B
Enterprise Value	451.80M

Important Dates

The last earnings date was Wednesday, February 25, 2026.

Earnings Date	Feb 25, 2026
Ex-Dividend Date	n/a

Share Statistics

OSL:NYKD has 326.55 million shares outstanding. The number of shares has decreased by -6.29% in one year.

Current Share Class	326.55M
Shares Outstanding	326.55M
Shares Change (YoY)	-6.29%
Shares Change (QoQ)	+9.25%
Owned by Insiders (%)	14.95%
Owned by Institutions (%)	32.15%
Float	161.49M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	226.40
PB Ratio	1.12
P/TBV Ratio	1.12
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-3.66
EV / Sales	98.94
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-1.52

Financial Position

The company has a current ratio of 10.00, with a Debt / Equity ratio of 0.03.

Current Ratio	10.00
Quick Ratio	10.00
Debt / Equity	0.03
Debt / EBITDA	n/a
Debt / FCF	-0.09
Interest Coverage	-228.70

Financial Efficiency

Return on equity (ROE) is -10.75% and return on invested capital (ROIC) is -79.39%.

Return on Equity (ROE)	-10.75%
Return on Assets (ROA)	-14.10%
Return on Invested Capital (ROIC)	-79.39%
Return on Capital Employed (ROCE)	-30.49%
Weighted Average Cost of Capital (WACC)	10.54%
Revenue Per Employee	77,399
Profits Per Employee	-2.09M
Employee Count	62
Asset Turnover	0.00
Inventory Turnover	n/a

Taxes

Income Tax	-55.01M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +66.00% in the last 52 weeks. The beta is 1.17, so OSL:NYKD's price volatility has been higher than the market average.

Beta (5Y)	1.17
52-Week Price Change	+66.00%
50-Day Moving Average	2.93
200-Day Moving Average	2.20
Relative Strength Index (RSI)	53.39
Average Volume (20 Days)	1,600,483

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, OSL:NYKD had revenue of NOK 4.57 million and -123.39 million in losses. Loss per share was -0.40.

Revenue	4.57M
Gross Profit	4.57M
Operating Income	-288.19M
Pretax Income	-178.40M
Net Income	-123.39M
EBITDA	-280.81M
EBIT	-288.19M
Loss Per Share	-0.40

Full Income Statement

Balance Sheet

The company has 607.75 million in cash and 25.71 million in debt, giving a net cash position of 582.05 million or 1.78 per share.

Cash & Cash Equivalents	607.75M
Total Debt	25.71M
Net Cash	582.05M
Net Cash Per Share	1.78
Equity (Book Value)	922.76M
Book Value Per Share	2.83
Working Capital	561.48M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -296.94 million and capital expenditures -383,066, giving a free cash flow of -297.32 million.

Operating Cash Flow	-296.94M
Capital Expenditures	-383,066
Free Cash Flow	-297.32M
FCF Per Share	-0.91

Full Cash Flow Statement

Margins

Gross Margin	100.00%
Operating Margin	-6,310.82%
Pretax Margin	-3,906.62%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 1.00, which amounts to a dividend yield of 29.94%.

Dividend Per Share	1.00
Dividend Yield	29.94%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	1
Payout Ratio	n/a
Buyback Yield	6.29%
Shareholder Yield	36.23%
Earnings Yield	-11.93%
FCF Yield	-28.76%

Dividend Details

Stock Splits

The last stock split was on July 7, 2020. It was a forward split with a ratio of 5.

Last Split Date	Jul 7, 2020
Split Type	Forward
Split Ratio	5

Scores

OSL:NYKD has an Altman Z-Score of 4.25.

Altman Z-Score	4.25
Piotroski F-Score	n/a